The global biosensors market was valued at $14,169.5 million in 2015, and it is expected to grow at a CAGR of 9.8% during 2016-2022. Based on application, the environment segment is expected to witness the fastest growth, CAGR of 11.5%, during the forecast period.
The global biosensors market is growing at a significant rate, due to increasing prevalence of diabetes and growing geriatric population. The increasing prevalence of chronic and lifestyle associated diseases, increasing demand for point of care testing and increasing application of biosensors in various industries are also driving the growth of the global biosensors market. However, factors such as strict regulatory requirement and reimbursement policy issues in healthcare systems are inhibiting the growth of the global market.
Explore Report with Detailed TOC on “Global Biosensors Market” at: https://www.psmarketresearch.com/market-analysis/biosensors-market
The information and data in the publication “Global Biosensors Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by technology, application and end user. The market numbers for countries are obtained through top-down approach. P&S Intelligence analysts and consultants interacted with authorities from leading companies of the concerned domain, to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online, and offline research.
Biosensors are complicated and effective device capable of fast detection and measuring wide spectrum in various applications. It has various applications in the field of healthcare, industrial process control, military application, environmental monitoring, agriculture and veterinary monitoring. The devices are easy to use, portable and acts as accurate detection device in a variety of applications. Glucose biosensors are one of the largest segments of biosensors in medical testing due to increasing prevalence of diabetes and health concerns.
Geographically, North America dominated the global market of biosensors in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, CAGR of 11.3%, during the forecast period.
Some of the key companies operating in the global biosensors market include Siemens AG, LifeSensors, Inc., Nova Biomedical Corporation, Abbott Laboratories, Inc., Johnson & Johnson, Medtronic, PLC, I-SENS, Inc., F. Hoffmann La Roche, TaiDoc Technology Corporation, and ACON Laboratories, Inc.
Global Biosensors Market Segmentation
By End User